Join our rare and specialty disease network and identify high risk patients in your practice.

Our advanced clinical dashboard enables urologists to identify patients with metastatic castration resistant prostate cancer (mCRPC).

Our AI platform helps identify high-risk patients, allowing the physician to advance treatment along the care pathway.

  • Identify high risk patients and accelerate diagnosis
  • AI-confirmed patient symptom analysis at the click of a button
  • Enable faster care for your patients.

Participation is easy. Fill in the form below, and then book a time to get started. We review results with you on a regular basis to answer any questions about the dashboard or the clinical criteria.

Please enter your information to book a time
with Shawn Ferron and the Khure team!

* By completing this form, you will also receive periodic emails about news and events. We respect your inbox and you can unsubscribe at any time.

Commitment to privacy.

Protecting the security and privacy of our customers’ data and their patient data is paramount for Khure Health. This includes complying with Canadian Data Protection regulations, including the Personal Information Protection and Electronic Documents Act (PIPEDA) and the Personal Health Information Protection Act(PHIPA).  Your patient data never leaves your office.
PHIPA & PIPEDA Compliant
Need more information? Read our FAQ.

Success

A Khure Health representative will be in touch shortly to confirm your meeting date and time.​

Return to Homepage